RALLYBIO CORP (RLYB) Stock Analyst Earnings Estimates
NASDAQ:RLYB - Nasdaq - US75120L1008 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A -62.94% | N/A -100.00% | N/A | N/A 341.52% | N/A 95.29% | N/A 63.25% | N/A 45.88% | ||||||
| EBITDA YoY % growth | -17.62M | -25.25M -43.30% | -45.53M -80.32% | -67.71M -48.72% | -78.782M -16.35% | N/A 15.84% | N/A -3.08% | N/A 32.84% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -17.65M | -25.31M -43.40% | -45.64M -80.32% | -67.88M -48.73% | -78.932M -16.28% | N/A 19.20% | N/A 14.09% | N/A -18.21% | N/A 107.72% | N/A 5,228.53% | N/A 120.49% | N/A 70.64% | N/A 48.80% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.11 48.89% | -1.84 12.80% | N/A 21.30% | N/A 6.92% | N/A -46.89% | N/A 15.51% | N/A -1.83% | N/A 30.54% | N/A 114.66% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 41.50% | -0.29 38.65% | -0.29 21.98% | -0.30 -17.30% | -0.30 -1.60% | -0.33 -13.91% | -0.26 9.89% | -0.28 7.02% | -0.31 -2.98% |
| Revenue Q2Q % growth | 76.5K | -100.00% | -100.00% | -100.00% | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | -16.32M 22.14% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.212M 32.68% | -13.158M 33.50% | -13.362M 21.56% | -13.566M -12.43% | -14.025M 1.32% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.26 42.22% | -0.36 | 0.10 | 27.67% |
| Q2 2024 Q2Q % growth | -0.37 19.57% | -0.38 | 0.01 | 3.01% |
| Q1 2024 Q2Q % growth | -0.47 -9.30% | -0.48 | 0.01 | 2.79% |
| Q4 2023 Q2Q % growth | -0.50 -8.70% | -0.46 | -0.04 | -9.05% |
| Q3 2023 Q2Q % growth | -0.45 25.00% | -0.52 | 0.07 | 13.25% |
| Q2 2023 Q2Q % growth | -0.46 19.30% | -0.49 | 0.03 | 5.62% |
| Q1 2023 Q2Q % growth | -0.43 10.42% | -0.50 | 0.07 | 13.21% |
| Q4 2022 Q2Q % growth | -0.46 -9.52% | -0.61 | 0.15 | 24.33% |
| Q3 2022 Q2Q % growth | -0.60 -62.16% | -0.55 | -0.05 | -8.43% |
| Q2 2022 Q2Q % growth | -0.57 79.64% | -0.61 | 0.04 | 6.08% |
| Q1 2022 Q2Q % growth | -0.48 | -0.46 | -0.02 | -4.00% |
| Q4 2021 Q2Q % growth | -0.42 | -0.40 | -0.02 | -5.58% |
| Q3 2021 Q2Q % growth | -0.37 | -0.90 | 0.53 | 59.01% |
| Q2 2021 Q2Q % growth | -2.80 | -2.86 | 0.06 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.03% | 10.28% | 0% | 7.06% |
| Revenue | -25% | N/A | 0% | 181.51% |